[The problem of hemobilia after transhepatic endobiliary interventions].

Objective: To study the causes of hemobilia occurring during percutaneous transhepatic drainage and to develop methods for its prevention.

Material And Methods: Treatment results were analyzed in 149 patients with tumors in the hepatopancretoduodenal area. Among the examined patients, there were 65 (43.6%) males and 84 (56.4%) females at the age of 33 to 91 years (mean 64.1 years) who underwent 881 different endobiliary interventions. The condition was severe in 46 (30.9%) patients, moderate in 89 (59.7%), and satisfactory in 14 (9.4%). Extensive abdominal surgery had been performed in 71 (47.6%) cases. The preadmission history of mechanical jaundice was 7 to 30 days (mean 18.5 days). Total bilirubin levels were in the range from 32.9 to 726 μmol/l (mean 249.4 μmol/l). Philips Allura V 3000 and Siemens Axiom Artis devices were used to exercise X-ray TV control during the interventions.

Results: The bile ducts were stented applying various models of expanding metallic stents in 93 (62.4%) of the 149 patients. A one-stage stenting protocol was used in 24 (25.8%) of the 93 patients and two-stage endobiliary stenting was carried out in 69 (74.2%). The other 56 (37.6%) of the 149 patients underwent only external-internal biliary drainage. Ten (6.7%) patients were noted to have different hemorrhagic complications as venous (4.7%, n = 7) and arterial (2%, n = 3) hemobilia.

Conclusion: X-ray surgical hemostatic procedures can ensure a final positive effect of transhepatic bile duct compression.